Xtl Biopharmaceuticals Ltd Stock Price Patterns

Intrinsic Valuation Low Real High 0.04 0.70 9.71 Details

Naive Forecast Low Next High 0.01 0.67 9.69 Details

Bollinger Band Projection (param) Lower Middle Band Upper 0.53 0.83 1.14 Details

XTL Biopharmaceutica After-Hype Price Density Analysis

XTL Biopharmaceutica Estimiated After-Hype Price Volatility

XTL Biopharmaceutica Stock Price Outlook Analysis

Notes

XTL Biopharmaceutica Hype Timeline

XTL Biopharmaceuticals is at this time traded for 0.85. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. XTL is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is at this time at 0.05%. %. The volatility of related hype on XTL Biopharmaceutica is about 7450.0%, with the expected price after the next announcement by competition of 0.84. About 38.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 1.9. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. XTL Biopharmaceuticals recorded a loss per share of 0.9. The entity last dividend was issued on the 10th of February 2017. The firm had 1:5 split on the 10th of February 2017. Given the investment horizon of 90 days the next expected press release will be in about 9 days. Check out XTL Biopharmaceutica Basic Forecasting Models to cross-verify your projections.

XTL Biopharmaceutica Related Hype Analysis

XTL Biopharmaceutica Additional Predictive Modules

Most predictive techniques to examine XTL price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for XTL using various technical indicators. When you analyze XTL charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of XTL Biopharmaceutica stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as XTL Biopharmaceuticals Ltd, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of XTL Biopharmaceutica based on analysis of XTL Biopharmaceutica hews, social hype, general headline patterns, and widely used predictive technical indicators.

When running XTL Biopharmaceutica's price analysis, check to measure XTL Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XTL Biopharmaceutica is operating at the current time. Most of XTL Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of XTL Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XTL Biopharmaceutica's price. Additionally, you may evaluate how the addition of XTL Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.